Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
2018 · The Lancet · 1,728 citations
https://doi.org/10.1016/s0140-6736(18)32261-x